Pathogenic variants in SCN2A are reported in a spectrum of neurodevelopmental disorders, including developmental and epileptic encephalopathies, benign familial neonatal-infantile seizures, episodic ataxia, and autism spectrum disorder and intellectual disability with and without seizures. This evidence concerns the gene SCN2A and Benign familial neonatal-infantile seizures.